Jardine Matheson completes I-MED deal: what it means for Jardine Matheson stock

Published on 10/07/2026 at 00:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

I-MED operates 215 clinics and supports more than 2 million patients. For Jardine Matheson stock this means 8.8 percent five-year returns.

Jardine Matheson, BMG507361001, Illustration mit AI erstellt.

Jardine Matheson (ISIN BMG507361001) completed its acquisition of I-MED Radiology Network on October 1, 2026, adding a 215-clinic medical imaging business to the group. As FT.com reported, the deal is Jardine Matheson's first major investment since its transition to an investment company in 2025.

I-MED adds a healthcare platform

I-MED operates 215 clinics across Australia and New Zealand and performs 7 million patient procedures each year, according to FT.com. Its network includes more than 500 radiologists and 4,000 staff, while its teleradiology operations support more than 2 million patients annually.

The transaction therefore gives Jardine Matheson a healthcare earnings platform with operating scale before any contribution from future expansion. The company said the investment begins building a new earnings growth pillar and fits its Asia Pacific-focused strategy.

Returns frame the acquisition

Jardine Matheson's investor page states that, as at December 31, 2025, five-year total shareholder return was 8.8 percent, group capital recycling reached US$4.8 billion and parent free cash flow was US$933 million. The same company page reports underlying net profit of US$1.68 billion, underlying earnings per share of US$5.72 and dividends per share of US$2.35.

Those figures give the I-MED deal a measurable portfolio context: Jardine Matheson is adding a new operating platform to a group that already reports billions of dollars in capital recycling and underlying profit. The acquisition's investment case consequently depends on integration and on whether I-MED can expand its clinic and teleradiology base.

Prior close sets the market reference

The prior close at Lang & Schwarz was EUR 50.69 on October 6, 2026. The reference price is the prior close because the latest quote record predates October 7, 2026.

The further course of trading is shown by the continuously updated real-time quote of Jardine Matheson stock.